The present invention is directed to the area of implantable electrical stimulation systems and methods of making and using the systems. The present invention is also directed to implantable electrical stimulation leads having a separate end conductor guide for contacts, as well as methods of making and using the leads and electrical stimulation systems.
Implantable electrical stimulation systems have proven therapeutic in a variety of diseases and disorders. For example, spinal cord stimulation systems have been used as a therapeutic modality for the treatment of chronic pain syndromes. Peripheral nerve stimulation has been used to treat chronic pain syndrome and incontinence, with a number of other applications under investigation. Functional electrical stimulation systems have been applied to restore some functionality to paralyzed extremities in spinal cord injury patients.
Stimulators have been developed to provide therapy for a variety of treatments. A stimulator can include a control module (with a pulse generator), one or more leads, and an array of stimulator electrodes on each lead. The stimulator electrodes are in contact with or near the nerves, muscles, or other tissue to be stimulated. The pulse generator in the control module generates electrical pulses that are delivered by the electrodes to body tissue.
One embodiment is an electrical stimulation lead having a proximal end and a distal end. The lead includes a cog-shaped conductor guide is disposed either at the proximal end or the distal end of the lead. The cog-shaped conductor guide includes a central core and multiple protrusions extending outwards from the core. A number of conductor tracks are defined within the cog-shaped conductor guide between adjacent protrusions of the cog-shaped conductor guide. Further, multiple electrodes are provided along the distal end of the lead. These electrodes are disposed over the cog-shaped conductor guide, when the cog-shaped conductor guide is disposed at the distal end of the lead. A number of terminals are disposed along the proximal end of the lead. In a case where the cog-shaped conductor guide is disposed at the proximal end of the lead, the terminals are disposed over the cog-shaped conductor guide. An elongated lead body extends from the electrodes to the terminals of the lead. Multiple conductors couple the electrodes to the terminals. Each of the conductors has an end portion positioned within one of the conductor tracks of the cog-shaped conductor guide.
Another embodiment is an electrical stimulation lead having a proximal end and a distal end. An end conductor guide is disposed either at the proximal end or the distal end of the lead. The end conductor guide has a generally cylindrical shape and a number of conductor tracks are formed over an exterior surface of the end conductor guide. Each of the conductor tracks extends longitudinally from a first end of the end conductor guide at least partway along the length of the end conductor guide. Protrusions are disposed between adjacent conductor tracks of the end conductor guide, providing it a cog-shaped cross-section at its first end. Electrodes are provided along the distal end of the lead. These electrodes are disposed over the end conductor guide, when the end conductor guide is disposed at the distal end of the lead. Terminals are provided along the proximal end of the lead. If the end conductor guide is disposed at the proximal end of the lead, then the terminals are disposed over the end conductor guide. The lead further includes an elongated lead body that extends from the electrodes to the terminals. Conductors couple the electrodes to the terminals. Each of the conductors has an end portion positioned within one of the conductor tracks of the end conductor guide.
Yet another embodiment is a method of making an electrical stimulation lead including providing a cog-shaped conductor guide having a central core and protrusions extending outward from the central core. Conductor tracks are defined within the conductor guide between adjacent protrusions of the conductor guide. The method further includes disposing end portions of each of a plurality of conductors in the conductor tracks of the cog-shaped conductor guide; disposing a plurality of contacts over the cog-shaped conductor guide; coupling the end portions of the conductors to the plurality of contacts; and disposing insulative spacers between adjacent contacts
Non-limiting and non-exhaustive embodiments of the present invention are described with reference to the following drawings. In the drawings, like reference numerals refer to like parts throughout the various figures unless otherwise specified.
For a better understanding of the present invention, reference will be made to the following Detailed Description, which is to be read in association with the accompanying drawings, wherein:
The present invention is directed to the area of implantable electrical stimulation systems and methods of making and using the systems. The present invention is also directed to implantable electrical stimulation leads having a separate end conductor guide for contacts, as well as methods of making and using the leads and electrical stimulation systems.
Suitable implantable electrical stimulation systems include, but are not limited to, at least one lead with one or more electrodes disposed along a distal end of the lead and one or more terminals disposed along the one or more proximal ends of the lead. Leads include, for example, percutaneous leads, paddle leads, and cuff leads. Examples of electrical stimulation systems with leads are found in, for example, U.S. Pat. Nos. 6,181,969; 6,516,227; 6,609,029; 6,609,032; 6,741,892; 7,949,395; 7,244,150; 7,672,734; 7,761,165; 7,974,706; 8,175,710; 8,224,450; and 8,364,278; and U.S. Patent Application Publication No. 2007/0150036, all of which are incorporated by reference.
It will be understood that the electrical stimulation system can include more, fewer, or different components and can have a variety of different configurations including those configurations disclosed in the electrical stimulation system references cited herein. For example, instead of a paddle body, the electrodes can be disposed in an array at or near the distal end of a lead body forming a percutaneous lead.
The lead 103 can be coupled to the control module 102 in any suitable manner. In
In
The control module 102 typically includes a connector housing 112 and a sealed electronics housing 114. An electronic subassembly 110 and an optional power source 120 are disposed in the electronics housing 114. A control module connector 144 is disposed in the connector housing 112. The control module connector 144 is configured and arranged to make an electrical connection between the lead 103 and the electronic subassembly 110 of the control module 102.
The electrical stimulation system or components of the electrical stimulation system, including the paddle body 104, the one or more of the lead bodies 106, and the control module 102, are typically implanted into the body of a patient. The electrical stimulation system can be used for a variety of applications including, but not limited to deep brain stimulation, neural stimulation, spinal cord stimulation, muscle stimulation, and the like.
The electrodes 134 can be formed using any conductive, biocompatible material. Examples of suitable materials include metals, alloys, conductive polymers, conductive carbon, and the like, as well as combinations thereof. In at least some embodiments, one or more of the electrodes 134 are formed from one or more of: platinum, platinum iridium, palladium, palladium rhodium, or titanium.
Any suitable number of electrodes 134 can be disposed on the lead including, for example, four, five, six, seven, eight, nine, ten, eleven, twelve, fourteen, sixteen, twenty-four, thirty-two, or more electrodes 134. In the case of paddle leads, the electrodes 134 can be disposed on the paddle body 104 in any suitable arrangement. In
The electrodes of the paddle body 104 (or one or more lead bodies 106) are typically disposed in, or separated by, a non-conductive, biocompatible material such as, for example, silicone, polyurethane, polyetheretherketone (“PEEK”), epoxy, and the like or combinations thereof. The one or more lead bodies 106 and, if applicable, the paddle body 104 and may be formed in the desired shape by any process including, for example, molding (including injection molding), casting, and the like. The non-conductive material typically extends from the distal ends of the one or more lead bodies 106 to the proximal end of each of the one or more lead bodies 106.
In the case of paddle leads, the non-conductive material typically extends from the paddle body 104 to the proximal end of each of the one or more lead bodies 106. Additionally, the non-conductive, biocompatible material of the paddle body 104 and the one or more lead bodies 106 may be the same or different. Moreover, the paddle body 104 and the one or more lead bodies 106 may be a unitary structure or can be formed as two separate structures that are permanently or detachably coupled together.
Terminals (e.g., 310 in
The electrically conductive wires (“conductors”) may be embedded in the non-conductive material of the lead body 106 or can be disposed in one or more lumens (not shown) extending along the lead body 106. In some embodiments, there is an individual lumen for each conductor. In other embodiments, two or more conductors may extend through a lumen. There may also be one or more lumens (not shown) that open at, or near, the proximal end of the one or more lead bodies 106, for example, for inserting a stylet to facilitate placement of the one or more lead bodies 106 within a body of a patient. Additionally, there may also be one or more lumens (not shown) that open at, or near, the distal end of the one or more lead bodies 106, for example, for infusion of drugs or medication into the site of implantation of the one or more lead bodies 106. In at least one embodiment, the one or more lumens are flushed continually, or on a regular basis, with saline, epidural fluid, or the like. In at least some embodiments, the one or more lumens can be permanently or removably sealable at the distal end.
The control module connector 144 defines at least one port into which a proximal end of the elongated device 300 can be inserted, as shown by directional arrows 312a and 312b. In
The control module connector 144 also includes a plurality of connector contacts, such as connector contact 314, disposed within each port 304a and 304b. When the elongated device 300 is inserted into the ports 304a and 304b, the connector contacts 314 can be aligned with a plurality of terminals 310 disposed along the proximal end(s) of the elongated device(s) 300 to electrically couple the control module 102 to the electrodes (134 of
A lead extension connector 322 is disposed on the lead extension 324. In
In at least some embodiments, the proximal end of the lead extension 324 is similarly configured and arranged as a proximal end of the lead 103 (or other elongated device 300). The lead extension 324 may include a plurality of electrically conductive wires (not shown) that electrically couple the connector contacts 340 to a proximal end 348 of the lead extension 324 that is opposite to the distal end 326. In at least some embodiments, the conductive wires disposed in the lead extension 324 can be electrically coupled to a plurality of terminals (not shown) disposed along the proximal end 348 of the lead extension 324. In at least some embodiments, the proximal end 348 of the lead extension 324 is configured and arranged for insertion into a connector disposed in another lead extension (or another intermediate device). In other embodiments (and as shown in
Turning to
In at least some embodiments, the plurality of conductor lumens 406 are encapsulated by the multi-lumen conductor guide 402 such that the conductor lumens 406 do not extend to an outer surface 408 of the multi-lumen conductor guide 402. In a case, when conductors (420 in
The central lumen 404 may be configured and arranged to receive a stylet. As discussed above, the stylet can be used for assisting in insertion and positioning of the lead 400 in the patient's body, and can be removed after the lead is implanted. The plurality of conductor lumens 406 are configured and arranged to receive conductors, which electrically couple the electrodes (134 of
A separate conductor guide can be provided one or both ends of the lead to, for example, facilitate manufacture or to alter properties (e.g., stiffness) at the ends of the lead or any combination of these factors.
In the illustrated embodiment, the central core 552 and the central lumen 558 have a circular cross-section. In other embodiments, the central core 552 or the central lumen 558 (or both) can have an elliptical, oval, or any other regular or irregular cross-sectional shape.
The multiple protrusions 554 extend longitudinally, parallel to the longitudinal axis of the end conductor guide 550 and are arranged circumferentially about the central core 552. In the illustrated embodiment, there are eight such protrusions arranged circumferentially and defining eight conductor tracks 556 between each pair of adjacent protrusions 554. The protrusions 554 give the end conductor guide 550 a star-shaped or cog-shaped cross-section, as illustrated, for example, in
Any suitable number of protrusions 554 can be disposed on the end conductor guide 550, including, for example, four, five, six, seven, eight, nine, ten, twelve, sixteen, twenty, twenty-four, or more protrusions 554. In at least some embodiments, the number of protrusions depends on the number of conductors (not shown) in the electrical stimulation lead.
The conductor tracks 556 extend longitudinally along the length of the end conductor guide 550, and are configured to receive the conductors (see
In the illustrated embodiment of
The end conductor guide 550 can be formed using any stiff, biocompatible material. Examples of suitable materials include, but are not limited to, silicone, polyurethane, polyetheretherketone (PEEK), polyvinyl chloride, epoxy and the like, as well as combinations thereof. In at least some embodiments, the end conductor guide 550 is formed of a material that can reflow to promote structural integrity of the array of electrodes and terminals.
A portion of each of the conductors 520 is disposed within the conductor lumens (such as 406 in
In at least some embodiments, stiffness or durometer (or both) of the end conductor guide 550 and the multi-lumen conductor guide 502 may differ. In one embodiment, the material of the end conductor guide 550 is stiffer with higher durometer as compared to that of the multi-lumen conductor guide 502, thereby, providing increased strength and durability to the proximal portion or the distal portion (whichever contains the end conductor guide) of the electrical stimulation lead. In other embodiments, the stiffness and durometer of the end conductor guide 550 and the multi-lumen conductor guide 502 are the same.
The retention sleeve 560 can be formed using any biocompatible material. Examples of suitable materials include metals, alloys, and the like, as well as combinations thereof. The retention sleeve 560 can be useful for securing the lead in a connector of a control module or lead extension. For example, a screw (see
The contacts 544 of the electrical stimulation lead can be either electrodes or terminals. In at least some embodiments, when the contacts 544 are disposed at the distal end of the electrical stimulation lead, the contacts 544 are electrodes, and when disposed at the proximal end of the electrical stimulation lead, the contacts 544 are terminals may be disposed to serve as conductive contacts. Non-conductive pacers 546 are disposed between adjacent contacts 544.
Once the conductors 520 are appropriately arranged in the conductor track 556 of the end conductor guide 550, a remaining portion of the conductor track 556 is optionally filled by a non-conductive filler material 562. The remaining portion in the conductor track 556 is an open space, unoccupied by the conductors 520. For instance, in a case where the end conductor guide 550 is disposed at the proximal end of the lead body 506, portion filled by the non-conductive filler material 562 is proximal to the weld in the conductor track 556. Such filling by the non-conductive filler material 562 can be done prior to, or after, the welding of the contact 544 to the conductor 520 placed in the conductor track 556. The non-conductive filler material 562 can be formed from any suitable material, such as polyurethane, silicone, and the like, and combinations thereof and may be a monofilament material. In at least some embodiments, the non-conductive filler material 562 is a material that can reflow during a reflow process.
In at least some embodiments, a non-conductive tip 564 is mounted on a terminal end of the end conductor guide 550, as shown in
The non-conductive tip 564 can be formed from any non-conductive, biocompatible material. Examples of suitable materials include polyurethane, silicone, or the like, as well as combinations thereof.
One method of making the electrical stimulation lead 500 includes positioning terminal portions of each of the conductors 520 in the conductor tracks 556 of the end conductor guide 550. Multiple contacts 544 are arranged over the end conductor guide 550, and each of the terminal portions of the multiple conductor tracks 556 is coupled to at least one of the contacts 544. The non-conductive spacers 546 are positioned between adjacent contacts 544 of the electrical stimulation lead 500. Finally, the optional non-conductive tip 564 is attached to the end of the end conductor guide 550, to assemble the electrical stimulation lead 500.
In at least some other embodiments, a tip 766 can be part of the end conductor guide 750, as illustrated in
Each of the conductor tracks 856 extends a different distance along the length of the end conductor guide 850. Each of the conductor tracks 856 have their terminal portions 868 terminating at different points. In at least some embodiments, the different distances of the conductor tracks 856 are representative of the different attachment sites of the various conductors with the contacts. For example, the lead body 506 and conductors 520 of
Some of the components (for example, power source 912, antenna 918, receiver 902, and processor 904) of the electrical stimulation system can be positioned on one or more circuit boards or similar carriers within a sealed housing of an implantable pulse generator, if desired. Any power source 912 can be used including, for example, a battery such as a primary battery or a rechargeable battery. Examples of other power sources include super capacitors, nuclear or atomic batteries, mechanical resonators, infrared collectors, thermally-powered energy sources, flexural powered energy sources, bioenergy power sources, fuel cells, bioelectric cells, osmotic pressure pumps, and the like including the power sources described in U.S. Pat. No. 7,437,193, incorporated herein by reference.
As another alternative, power can be supplied by an external power source through inductive coupling via the optional antenna 918 or a secondary antenna. The external power source can be in a device that is mounted on the skin of the user or in a unit that is provided near the user on a permanent or periodic basis.
If the power source 912 is a rechargeable battery, the battery may be recharged using the optional antenna 918, if desired. Power can be provided to the battery for recharging by inductively coupling the battery through the antenna to a recharging unit 916 external to the user. Examples of such arrangements can be found in the references identified above.
In one embodiment, electrical current is emitted by the electrodes 134 on the paddle or lead body to stimulate nerve fibers, muscle fibers, or other body tissues near the electrical stimulation system. A processor 904 is generally included to control the timing and electrical characteristics of the electrical stimulation system. For example, the processor 904 can, if desired, control one or more of the timing, frequency, strength, duration, and waveform of the pulses. In addition, the processor 904 can select which electrodes can be used to provide stimulation, if desired. In some embodiments, the processor 904 may select which electrode(s) are cathodes and which electrode(s) are anodes. In some embodiments, the processor 904 may be used to identify which electrodes provide the most useful stimulation of the desired tissue.
Any processor can be used and can be as simple as an electronic device that, for example, produces pulses at a regular interval or the processor can be capable of receiving and interpreting instructions from an external programming unit 908 that, for example, allows modification of pulse characteristics. In the illustrated embodiment, the processor 904 is coupled to a receiver 902 which, in turn, is coupled to the optional antenna 918. This allows the processor 904 to receive instructions from an external source to, for example, direct the pulse characteristics and the selection of electrodes, if desired.
In one embodiment, the antenna 918 is capable of receiving signals (e.g., RF signals) from an external telemetry unit 906 which is programmed by a programming unit 908. The programming unit 908 can be external to, or part of, the telemetry unit 906. The telemetry unit 906 can be a device that is worn on the skin of the user or can be carried by the user and can have a form similar to a pager, cellular phone, or remote control, if desired. As another alternative, the telemetry unit 906 may not be worn or carried by the user but may only be available at a home station or at a clinician's office.
The programming unit 908 can be any unit that can provide information to the telemetry unit 906 for transmission to the electrical stimulation system 900. The programming unit 908 can be part of the telemetry unit 906 or can provide signals or information to the telemetry unit 906 via a wireless or wired connection. One example of a suitable programming unit is a computer operated by the user or clinician to send signals to the telemetry unit 906.
The signals sent to the processor 904 via the antenna 918 and receiver 902 can be used to modify or otherwise direct the operation of the electrical stimulation system. For example, the signals may be used to modify the pulses of the electrical stimulation system such as modifying one or more of pulse duration, pulse frequency, pulse waveform, and pulse strength. The signals may also direct the electrical stimulation system 900 to cease operation, to start operation, to start charging the battery, or to stop charging the battery. In other embodiments, the stimulation system does not include an antenna 918 or receiver 902 and the processor 904 operates as programmed.
Optionally, the electrical stimulation system 900 may include a transmitter (not shown) coupled to the processor 904 and the antenna 918 for transmitting signals back to the telemetry unit 906 or another unit capable of receiving the signals. For example, the electrical stimulation system 900 may transmit signals indicating whether the electrical stimulation system 900 is operating properly or not or indicating when the battery needs to be charged or the level of charge remaining in the battery. The processor 904 may also be capable of transmitting information about the pulse characteristics so that a user or clinician can determine or verify the characteristics.
The above specification, examples and data provide a description of the manufacture and use of the composition of the invention. Since many embodiments of the invention can be made without departing from the spirit and scope of the invention, the invention also resides in the claims hereinafter appended.
This application claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application Ser. No. 61/625,587 filed on Apr. 17, 2012, and U.S. Provisional Patent Application Ser. No. 61/745,354 filed on Dec. 21, 2012, which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
5330522 | Kreyenhagen | Jul 1994 | A |
5554176 | Maddison et al. | Sep 1996 | A |
5584873 | Shoberg et al. | Dec 1996 | A |
5855552 | Houser et al. | Jan 1999 | A |
5865843 | Baudino | Feb 1999 | A |
5893885 | Webster, Jr. | Apr 1999 | A |
6181969 | Gord | Jan 2001 | B1 |
6181971 | Doan | Jan 2001 | B1 |
6304784 | Allee et al. | Oct 2001 | B1 |
6516227 | Meadows et al. | Feb 2003 | B1 |
6609029 | Mann et al. | Aug 2003 | B1 |
6609032 | Woods et al. | Aug 2003 | B1 |
6741892 | Meadows et al. | May 2004 | B1 |
7006859 | Osorio et al. | Feb 2006 | B1 |
7244150 | Brase et al. | Jul 2007 | B1 |
7437193 | Parramon et al. | Oct 2008 | B2 |
7450997 | Pianca et al. | Nov 2008 | B1 |
7672734 | Anderson et al. | Mar 2010 | B2 |
7761165 | He et al. | Jul 2010 | B1 |
7783359 | Meadows | Aug 2010 | B2 |
7792590 | Pianca et al. | Sep 2010 | B1 |
7809446 | Meadows | Oct 2010 | B2 |
7949395 | Kuzma | May 2011 | B2 |
7974706 | Moffitt et al. | Jul 2011 | B2 |
8224460 | He | May 2012 | B2 |
8224450 | Brase | Jul 2012 | B2 |
8271094 | Moffitt et al. | Sep 2012 | B1 |
8295944 | Howard et al. | Oct 2012 | B2 |
8364278 | Pianca et al. | Jan 2013 | B2 |
8391935 | McDonald | Mar 2013 | B2 |
20010018607 | Borgersen et al. | Aug 2001 | A1 |
20030204232 | Sommer et al. | Oct 2003 | A1 |
20040064024 | Sommer | Apr 2004 | A1 |
20040097965 | Gardeski et al. | May 2004 | A1 |
20050027342 | Shoberg et al. | Feb 2005 | A1 |
20050222659 | Olsen et al. | Oct 2005 | A1 |
20060089691 | Kaplan et al. | Apr 2006 | A1 |
20070150036 | Anderson | Jun 2007 | A1 |
20070197892 | Shen et al. | Aug 2007 | A1 |
20070293922 | Soltis et al. | Dec 2007 | A1 |
20080004618 | Johnson et al. | Jan 2008 | A1 |
20090187222 | Barker | Jul 2009 | A1 |
20090198312 | Barker | Aug 2009 | A1 |
20090222073 | Flowers et al. | Sep 2009 | A1 |
20090276021 | Meadows et al. | Nov 2009 | A1 |
20100076535 | Pianca et al. | Mar 2010 | A1 |
20100137928 | Duncan et al. | Jun 2010 | A1 |
20100268298 | Moffitt et al. | Oct 2010 | A1 |
20100298761 | Staal et al. | Nov 2010 | A1 |
20100306997 | Pardo et al. | Dec 2010 | A1 |
20110004267 | Meadows | Jan 2011 | A1 |
20110005069 | Pianca | Jan 2011 | A1 |
20110078900 | Pianca et al. | Apr 2011 | A1 |
20110130817 | Chen | Jun 2011 | A1 |
20110130818 | Chen | Jun 2011 | A1 |
20110196229 | Weiss et al. | Aug 2011 | A1 |
20110238129 | Moffitt et al. | Sep 2011 | A1 |
20110313500 | Barker et al. | Dec 2011 | A1 |
20120016378 | Pianca et al. | Jan 2012 | A1 |
20120046710 | DiGiore et al. | Feb 2012 | A1 |
20120071949 | Pianca et al. | Mar 2012 | A1 |
20120165911 | Pianca | Jun 2012 | A1 |
20120197375 | Pianca et al. | Aug 2012 | A1 |
20120203316 | Moffitt et al. | Aug 2012 | A1 |
20120203320 | DiGiore et al. | Aug 2012 | A1 |
20120203321 | Moffitt et al. | Aug 2012 | A1 |
20120232629 | Bloemer et al. | Sep 2012 | A1 |
Entry |
---|
U.S. Appl. No. 12/177,823, filed Jul. 22, 2008. |
U.S. Appl. No. 61/022,953, filed Jan. 23, 2008. |
U.S. Appl. No. 61/170,037, filed Apr. 16, 2009. |
U.S. Appl. No. 61/316,759, filed Mar. 23, 2010. |
U.S. Appl. No. 61/494,247, filed Jun. 7, 2011. |
U.S. Appl. No. 61/554,861, filed Nov. 2, 2011. |
U.S. Appl. No. 61/591,046, filed Jan. 26, 2012. |
U.S. Appl. No. 61/625,587, filed Apr. 17, 2012. |
Official Communication for U.S. Appl. No. 13/864,030 dated Mar. 19, 2014. |
Official Communication for U.S. Appl. No. 13/864,030 dated Dec. 23, 2014. |
Number | Date | Country | |
---|---|---|---|
20130274844 A1 | Oct 2013 | US |
Number | Date | Country | |
---|---|---|---|
61625587 | Apr 2012 | US | |
61745354 | Dec 2012 | US |